Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
9596089
Reference Type
Journal Article
Title
Elevated risk of papillary thyroid cancer in Korean patients with Hashimoto's thyroiditis
Author(s)
Kim, KW; Park, YJ; Kim, EH; Park, SY; Park, DJ; Ahn, SH; Park, DJ; Jang, HC; Cho, BY
Year
2011
Is Peer Reviewed?
1
Journal
Head & Neck
ISSN:
1043-3074
EISSN:
1097-0347
Volume
33
Issue
5
Page Numbers
691-695
Language
English
PMID
21484918
DOI
10.1002/hed.21518
Abstract
BACKGROUND:
Hashimoto's thyroiditis (HT) and higher levels of thyroid-stimulating hormone (TSH) have been proposed as risk factors for papillary thyroid cancer (PTC), but this issue is still being debated. The purpose of this study was whether HT was related to the risk of PTC over TSH.
METHODS:
We enrolled 1329 patients (1028 with PTC, 52 with follicular thyroid cancer, and 249 with benign disease) of 1490 patients who underwent thyroidectomy.
RESULTS:
The TSH concentration was not different among patients with PTC or benign disease. Our study showed that men (odds ratio [OR] = 1.54; p = .049) and the presence of HT (OR = 2.96; p <.001) increased the risk of PTC. Moreover, HT was associated with multifocal cancer (p = .005) and smaller tumor size (p = .031), but it did not influence the extrathyroidal invasion or nodal metastasis.
CONCLUSION:
Clinicians who deal with thyroid nodules should pay particular attention to HT because it is a stronger predictor for PTC than other risk factors.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity